Home > Chemicals & Materials > Polymers > Medical Polymers > Polyglycerol Sebacate (PGS) Market

Polyglycerol Sebacate (PGS) Market Trends

Report ID: GMI3101
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Polyglycerol Sebacate Market Trends

The polyglycerol Sebacate (PGS) industry is experiencing notable growth in the medical industry due to its advanced applications in tissue engineering and regenerative medicine. PGS’s biocompatibility, customizable degradation rates, and mechanical properties make it ideal for creating scaffolds and matrices that support tissue regeneration. Additionally, the rising demand for biomedical textiles, which utilize PGS for enhanced healing and improved surgical outcomes, further fuels market expansion. These trends underscore PGS’s growing role as a crucial material in developing innovative medical solutions and advancing patient care, positioning it favourably in the evolving healthcare landscape.

Authors: Kiran Pulidindi, Manish Verma

Frequently Asked Questions (FAQ) :

The market size of polyglycerol sebacate reached USD 65.49 million in 2023 and is anticipated to grow at a 10.6% CAGR from 2024 to 2032.

The tissue engineering application segment held a 45% market share in 2023, amounting to USD 29.47 million, and is projected to grow at a 9% CAGR from 2024 to 2032.

The soft gel segment is projected to capture USD 43.35 million and demonstrate a 9.6% CAGR by 2032, due to their flexibility and biocompatibility, making them ideal for drug delivery systems and tissue scaffolding.

The North America market is projected to achieve USD 74.34 million, with a CAGR of 12% from 2024 to 2032, owing to a rise in the aging population and an increase in lifestyle diseases such as obesity.

Leading players in the market include BASF SE, Cambridge Polymers Group, Evonik Industries AG, Fuso Chemical Co., Ltd., Orthofix International NV, Polymers LLC, PolySciTech (Akina, Inc.), Resinex, Secant LLC, Sigma-Aldrich (Merck Group), and Synthecon Inc.